|
1
|
Yip TT, Ngan RK, Fong AH and Law SC:
Application of circulating plasma/serum EBV DNA in the clinical
management of nasopharyngeal carcinoma. Oral Oncol. 50:527–538.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sze H, Blanchard P, Ng WT, Pignon JP and
Lee AW: Chemotherapy for nasopharyngeal carcinoma-current
recommendation and controversies. Hematol Oncol Clin North Am.
29:1107–1122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wei WI and Sham JS: Nasopharyngeal
carcinoma. Lancet. 365:2041–2054. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Z, Wang Y, Ren H, Jin Y and Guo Y:
ZNRF3 inhibits the invasion and tumorigenesis in nasopharyngeal
carcinoma cells by inactivating the Wnt/β-catenin pathway. Oncol
Res. 25:571–577. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang R, Li H, Guo X, Wang Z, Liang S and
Dang C: IGF-I induces epithelial-to-mesenchymal transition via the
IGF-IR-Src-MicroRNA-30a-E-cadherin pathway in nasopharyngeal
carcinoma cells. Oncol Res. 24:225–231. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ji S, Zhang B, Kong Y, Ma F and Hua Y:
MiR-326 inhibits gastric cancer cell growth through down regulating
NOB1. Oncol Res. Oct 11–2016.(Epub ahead of print).
|
|
7
|
Liu X, Li J, Yu Z, Sun R and Kan Q:
miR-935 promotes liver cancer cell proliferation and migration by
targeting SOX7. Oncol Res. 25:427–435. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen Z, Tang ZY, He Y, Liu LF, Li DJ and
Chen X: miRNA-205 is a candidate tumor suppressor that targets ZEB2
in renal cell carcinoma. Oncol Res Treat. 37:658–664. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liang J, Zhang Y, Jiang G, Liu Z, Xiang W,
Chen X, Chen Z and Zhao J: MiR-138 induces renal carcinoma cell
senescence by targeting EZH2 and is downregulated in human clear
cell renal cell carcinoma. Oncol Res. 21:83–91. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li X, Li Y and Lu H: MiR-1193 suppresses
proliferation and invasion of human breast cancer cells through
directly targeting IGF2BP2. Oncol Res. 25:579–585. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu X, Liu Y, Wu S, Shi X, Li L, Zhao J
and Xu H: Tumor-suppressing effects of miR-429 on human
osteosarcoma. Cell Biochem Biophys. 70:215–224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lv H, Zhang Z, Wang Y, Li C, Gong W and
Wang X: MicroRNA-92a promotes colorectal cancer cell growth and
migration by inhibiting KLF4. Oncol Res. 23:283–290. 2016.
View Article : Google Scholar
|
|
14
|
Wang G, Fu Y, Liu G, Ye Y and Zhang X:
miR-218 inhibits proliferation, migration, and EMT of gastric
cancer cells by targeting WASF3. Oncol Res. 25:355–364. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu K, He Y, Xia C, Yan J, Hou J, Kong D,
Yang Y and Zheng G: MicroRNA-15a inhibits proliferation and induces
apoptosis in CNE1 nasopharyngeal carcinoma cells. Oncol Res.
24:145–151. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu X, Lv XB, Wang XP, Sang Y, Xu S, Hu K,
Wu M, Liang Y, Liu P, Tang J, et al: miR-138 suppressed
nasopharyngeal carcinoma growth and tumorigenesis by targeting the
CCND1 oncogene. Cell Cycle. 11:2495–2506. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Deng M, Ye Q, Qin Z, Zheng Y, He W, Tang
H, Zhou Y, Xiong W, Zhou M, Li X, et al: miR-214 promotes
tumorigenesis by targeting lactotransferrin in nasopharyngeal
carcinoma. Tumour Biol. 34:1793–1800. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Alajez NM, Lenarduzzi M, Ito E, Hui AB,
Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, et al: miR-218
suppresses nasopharyngeal cancer progression through downregulation
of survivin and the SLIT2-ROBO1 pathway. Cancer Res. 71:2381–2391.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yi C, Wang Q, Wang L, Huang Y, Li L, Liu
L, Zhou X, Xie G, Kang T, Wang H, et al: miR-663, a microRNA
targeting p21(WAF1/CIP1), promotes the proliferation and
tumorigenesis of nasopharyngeal carcinoma. Oncogene. 31:4421–4433.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Uzhachenko R, Shanker A, Yarbrough WG and
Ivanova AV: Mitochondria, calcium, and tumor suppressor Fus1: At
the crossroad of cancer, inflammation, and autoimmunity.
Oncotarget. 6:20754–20772. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Meng J, Majidi M, Fang B, Ji L, Bekele BN,
Minna JD and Roth JA: The tumor suppressor gene TUSC2 (FUS1)
sensitizes NSCLC to the AKT inhibitor MK2206 in LKB1-dependent
manner. PLoS One. 8:e770672013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
da Costa Prando E, Cavalli LR and Rainho
CA: Evidence of epigenetic regulation of the tumor suppressor gene
cluster flanking RASSF1 in breast cancer cell lines. Epigenetics.
6:1413–1424. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xin J, Zhang XK, Xin DY, Li XF, Sun DK, Ma
YY and Tian LQ: FUS1 acts as a tumor-suppressor gene by
upregulating miR-197 in human glioblastoma. Oncol Rep. 34:868–876.
2015.PubMed/NCBI
|
|
24
|
Zhou YB, Huang ZX, Ren CP, Zhu B and Yao
KT: Screening and preliminary analysis of the apoptosis- and
proliferation-related genes in nasopharyngeal carcinoma. Nan Fang
Yi Ke Da Xue Xue Bao. 29:645–647. 2009.(In Chinese). PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pan J, Hu H, Zhou Z, Sun L, Peng L, Yu L,
Sun L, Liu J, Yang Z and Ran Y: Tumor-suppressive mir-663 gene
induces mitotic catastrophe growth arrest in human gastric cancer
cells. Oncol Rep. 24:105–112. 2010.PubMed/NCBI
|
|
27
|
Tili E, Michaille JJ, Alder H, Volinia S,
Delmas D, Latruffe N and Croce CM: Resveratrol modulates the levels
of microRNAs targeting genes encoding tumor-suppressors and
effectors of TGFβ signaling pathway in SW480 cells. Biochem
Pharmacol. 80:2057–2065. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sand M, Skrygan M, Sand D, Georgas D,
Gambichler T, Hahn SA, Altmeyer P and Bechara FG: Comparative
microarray analysis of microRNA expression profiles in primary
cutaneous malignant melanoma, cutaneous malignant melanoma
metastases, and benign melanocytic nevi. Cell Tissue Res.
351:85–98. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu ZY, Zhang GL, Wang MM, Xiong YN and
Cui HQ: MicroRNA-663 targets TGFB1 and regulates lung cancer
proliferation. Asian Pac J Cancer Prev. 12:2819–2823.
2011.PubMed/NCBI
|
|
30
|
Li Q, Cheng Q, Chen Z, Peng R, Chen R, Ma
Z, Wan X, Liu J, Meng M, Peng Z and Jiang B: MicroRNA-663 inhibits
the proliferation, migration and invasion of glioblastoma cells via
targeting TGF-β1. Oncol Rep. 35:1125–1134. 2016.PubMed/NCBI
|
|
31
|
Zang W, Wang Y, Wang T, Du Y, Chen X, Li M
and Zhao G: miR-663 attenuates tumor growth and invasiveness by
targeting eEF1A2 in pancreatic cancer. Mol Cancer. 14:372015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Orlandella FM, Di Maro G, Ugolini C,
Basolo F and Salvatore G: TWIST1/miR-584/TUSC2 pathway induces
resistance to apoptosis in thyroid cancer cells. Oncotarget.
7:70575–70588. 2016.PubMed/NCBI
|
|
33
|
Du L, Schageman JJ, Subauste MC, Saber B,
Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD and
Pertsemlidis A: miR-93, miR-98, and miR-197 regulate expression of
tumor suppressor gene FUS1. Mol Cancer Res. 7:1234–1243. 2009.
View Article : Google Scholar : PubMed/NCBI
|
